Skip to main content
. 2020 Jun 26;8:91. doi: 10.1186/s40478-020-00965-y

Table 1.

Subject demographics. Demographics for each case used for immunohistochemical analysis are shown. PMI = post mortem interval (hours between death and tissue harvest); C9orf72 = presence or absence of C9orf72 hexanucleotide repeat expansion; sALS = sporadic (i.e., non-familial) ALS; AD = Alzheimer’s disease, Braak stage VI; FTLD-TDP = frontotemporal lobar degeneration with TDP-43 proteinopathy

Subject Group C9orf72 Age Sex PMI Hippocampus Spinal Cord
1 Control no 54 M 6 yes yes
2 Control no 53 F 4 yes yes
3 Control no 51 F 5 yes yes
4 Control no 76 M 13 yes yes
5 Control no 57 M 2 yes yes
6 Control no 48 M 2 yes yes
7 Control no 58 F 5 yes yes
8 Control no 76 M 14 yes no
9 Control no 82 F 5 yes yes
10 Control no 57 F 11 yes yes
11 sALS no 62 M 7 no yes
12 sALS no 50 F 7 no yes
13 sALS no 60 F 4 no yes
14 sALS no 59 M 4 yes yes
15 sALS no 77 F 4 yes yes
16 sALS no 79 F 4 yes yes
17 sALS no 52 F 21 yes yes
18 sALS no 45 M 7 yes no
19 sALS no 65 M 5 yes no
20 sALS no 66 M 18 yes yes
21 sALS no 53 F 12 yes yes
22 sALS no 73 F 6 no yes
23 sALS no 59 M 5 no yes
24 sALS no 48 F 5 no yes
25 ALS yes 68 M 4 no yes
26 ALS yes 43 M 6 no yes
27 ALS yes 63 F 4 no yes
28 AD no 71 M 4 yes no
29 AD no 84 F 5 yes no
30 AD no 85 M 5 yes no
31 AD no 73 F 4 yes no
32 AD no 71 F 5 yes no
33 FTLD-TDP no 69 M 6 yes no
34 FTLD-TDP no 67 M > 24 yes no
35 FTLD-TDP no 69 M 6 yes no
36 FTLD-TDP no 85 M 3 yes no
37 FTLD-TDP no 91 F 8 yes no
38 FTLD-TDP no 79 M 7 yes no